Evidence map›Paper›PMID 40104517›Full record

ArticleChina CDC weekly2025

Risk Assessment of Cardiovascular Disease in HIV Infected Individuals Receiving Antiretroviral Therapy - Shanghai Municipality, China, 2023.

Xiaomeng Li, Lin Wang, Li Liu, Zihui Zhao, Ye Li, Jiawei Huang, Huiqin Yan, Yiping Jin, Meiyan Sun, Jun Chen and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiaomeng Li *Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Lin Wang *Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Li LiuShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Zihui ZhaoShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Ye LiShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Jiawei HuangShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Huiqin YanShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yiping JinShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Meiyan SunShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Jun ChenShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yingying DingSchool of Public Health, Fudan University, Shanghai, China.
Renfang ZhangShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yinzhong ShenShanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: Antiretroviral therapy (ART) is transforming human immunodeficiency virus (HIV) infection into a chronic condition, leading to an altered disease spectrum in patients. The risk of cardiovascular disease (CVD) in HIV-infected individuals are twice that of the general population. What is added by this report?: This study demonstrates elevated cardiovascular risk among the HIV population. The findings reveal that traditional CVD risk factors are prevalent among people living with HIV but remain inadequately addressed in clinical practice. What are the implications for public health practice?: These findings underscore both the necessity and urgency of implementing systematic CVD risk screening and intervention programs for HIV population. Furthermore, the study emphasizes the critical need to develop CVD screening tools specifically calibrated for the HIV population in China.

Indexed as

Atherosclerotic cardiovascular diseaseHIVrisk assessment

Identifiers

PMID40104517
PMCPMC11911657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.